Clinical trials of a potential coronavirus vaccine developed by China's Sinovac has got the go-ahead in Brazil.
Trials will be conducted by 12 research centres in Sao Paulo, Rio de Janeiro, Minas Gerais, Brasilia, Rio Grande do Sul and Parana.
According to Brazilian health regulator Anvisa, the agreement with Sinovac will also look at the transference of technology to produce the potential vaccine locally.
It comes as the country surpassed 1.5 million confirmed cases of COVID-19, with the death toll at 63,174.
At least 22 killed in collapse of two buildings in Morocco's old city of Fez
Putin meets Indonesia's Prabowo to discuss military and energy ties, wheat exports
Air India urges overhaul in compliance culture after flying Airbus without permit
'This is the end': Australian teens mourn loss of social media as ban begins
Twelve killed in residential fire in southern China, Xinhua reports
